The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended January 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
HealthEquity (HQY) came out with quarterly earnings of $0.69 per share, missing the Zacks Consensus Estimate of $0.71 per share. This compares to earnings of $0.63 per share a year ago.
HealthEquity, Inc. HQY will release its fourth-quarter financial results, after the closing bell, on Tuesday, March 18.
Investors with an interest in Medical Services stocks have likely encountered both Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
HealthEquity (NASDAQ:HQY) is down nearly 15% in the past month, presenting a potential buying opportunity. The company recently beat Q3'25 earnings expectations in both EPS and revenue. HQY offers CDBs such as HSAs, which have seen rapid growth over the past decade, and are expected to keep growing into the future.
Evaluate the expected performance of HealthEquity (HQY) for the quarter ended January 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
HQY's sustained strength in HSAs raises optimism about the stock.
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or HealthEquity (HQY). But which of these two stocks is more attractive to value investors?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
HQY's sustained strength in HSAs raises optimism about the stock.